Clinical characteristics of drug-induced liver injury and related risk factors
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drug-induced liver injury (DILI) is often undiagnosed or misdiagnosed clinically because of diagnostic difficulties caused by lack of laboratory-specific serological markers. In this study, we comprehensively assessed the clinical characteristics, laboratory indices, hepatotoxic drugs, risk factors and outcomes concerning DILI, and explored the similarities in mechanisms between Chinese and Western drug-induced DILI. Patients with a first diagnosis of DILI and a Roussel Uclaf Causality Assessment Method (RUCAM) score >3 points were enrolled for systematic retrospective study. Their clinical characteristics, clinical classification, risk factors, laboratory indices, hepatotoxic drugs and outcomes were analyzed. Cholestatic patients had the highest alkaline phosphatase (ALP) and prothrombin time activity (PTA) levels (P<0.05). Patients with medication time ≥30 days had significantly higher positive rate of autoantibodies than those with medication time <30 days. Odds ratio values for DILI-related factors such as hepatobiliary diseases, immune dysfunction, diabetes, hypertension, chronic alcohol consumption and age ≥45 years were 6.552, 6.130, 3.774, 2.801, 2.002 and 1.838, respectively. Pathogeneses of Chinese and Western drug-induced DILI may be substantially the same. DILI accompanied with autoantibody positivity may indicate severe liver injury outcome. Hepatobiliary diseases, diabetes and hypertension are likely to increase drug susceptibility, and more prone to cause liver injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347 · cited 1×
“A study found no significant association of age and gender with DILI occurrence (7), but with increasing age, patients are prone to develop age-related diseases, their organs deteriorate gradually, and hepatic drug metabolizing capacity weakens, thus increasing burden on the liver (8).”
Cited by
Recent progress in the development of fluorescent probes for imaging pathological oxidative stress
Geng, Y., Wang, Z., Zhou, J., Zhu, M., Liu, J., & James, T. D. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00172a · Cited by 351
Systematic review of published data on herb induced liver injury
Byeon, J.-H., Kil, J.-H., Ahn, Y.-C., & Son, C.-G. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.01.006 · Cited by 105
Teschke, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00730 · Cited by 62
Teschke, R., Eickhoff, A., Wolff, A., & Xuan, T. D. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0124-7 · Cited by 14
Ayurvedic drug induced liver injury
Dalal, K. K., Holdbrook, T., & Peikin, S. R. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i31.1205 · Cited by 12
Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types
Zhang, C., Wu, Y., Yuan, S., Dou, X., Sheng, Q., Wang, J., Tian, W., Yao, L., & Ding, Y. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-06030-6 · Cited by 6
Xiong, Y.-T., Wang, J.-F., Li, L., Bai, Z.-F., Liu, Y., Huang, A., Wang, K.-X., Fu, Y., Yang, W., Guo, C., et al. (2024) · iLIVER · doi:10.1016/j.iliver.2024.100095 · Cited by 6
“A previous survey of 513 DILI cases demonstrated that the risk of DILI in hypertensive patients was 2.801 times higher than that in non-hypertensive patients [33].”
Influential
Metadata
- Authors
- Lu, R.-J., Zhang, Y., Tang, F.-L., Zheng, Z.-W., Fan, Z.-D., Zhu, S.-M., Qian, X.-F., & Liu, N.-N.
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2016-08-29
- Volume
- 12
- Issue
- 4
- Pages
- 2606-2616
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- OpenAlex
- W2511229837
- Cited by
- 55
- References
- 2
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.